- About the Lecture
-
About the Lecture
We've deciphered the human genome and moved into proteomics-the study of the individual proteins that the genes code for. Such advances anticipate the day when drugs are not only targeted at molecular workings or specific diseases but tailor-made for each individual's genetic makeup. - About the Speakers
-
About the Speakers
Moderator: Rebecca Henderson '81
Eastman Kodak LFM Professor, MIT Sloan School
Rebecca Henderson specializes in technology strategy. Her current research focuses upon the pharmaceutical and biotechnology industries. She received an undergraduate degree in Mechanical Engineering from MIT in 1981 and a doctorate in Business Economics from Harvard University in 1988. She spent 1981-1983 working for the London office of McKinsey and Company.
Her publications include “Underinvestment and Incompetence as Responses to Radical Innovation: Evidence from the Photolithographic Industry” in the Rand Journal of Economics, and “Architectural Innovation: The Reconfiguration of Existing Product Technologies and The Failure of Established Firms” with Kim Clark, in Administrative Science Quarterly.
Henderson sits on the Board of the Whitehead Institute for Biomedical Research and on the Board of the Linbeck Corporation. She was recently retained by the Department of Justice as an Expert Witness in connection with the Remedies phase of the Microsoft case, and in 2001 was voted “Teacher of the Year” at MIT Sloan School of Management.Darlene Solomon PhD '85
Director of the Life Science Technologies Laboratory, Agilent Technologies
Jose B. Cibelli
Vice-President of Research, A.C.T. Group
Benjamin Cravatt
Sripps Research Institute TR100 Finalist
David Sabatini
Whitehead Institute for Biomedical Research TR100 Finalist
- About the Host
-
About the Host
Technology Review
Video Player
Personalized Medicine
- Moderator: Rebecca Henderson '81
- Darlene Solomon PhD '85
Jose B. Cibelli
Benjamin Cravatt
David Sabatini - May 23, 2002
- Running Time: 00:17:59


